Lantheus Holdings Inc (LNTH) USD0.01

Sell:$89.75Buy:$94.21$2.81 (3.14%)

NASDAQ:1.35%
Market closed | Prices delayed by at least 15 minutes
Sell:$89.75
Buy:$94.21
Change:$2.81 (3.14%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$89.75
Buy:$94.21
Change:$2.81 (3.14%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol. It has pre-clinical assets, specifically the TROP2 and DUNP19.

Key people

Mary Anne Heino
Chairman of the Board
Paul M. Blanchfield
President
Brian A. Markison
Chief Executive Officer, Director
Robert J. Marshall
Chief Financial Officer, Treasurer
Jamie Spaeth
Chief People Officer
Daniel M. Niedzwiecki
Chief Administrative Officer, General Counsel, Corporate Secretary
Jean-Claude Provost
Chief Scientific Officer
Jeffrey Humphrey
Chief Medical Officer
Etienne Montagut
Chief Business Officer
Amanda Morgan
Chief Commercial Officer
Julie H. Mchugh
Lead Independent Director
Minnie Baylor-Henry
Independent Director
Gerard Ber
Independent Director
Julie Eastland
Independent Director
Samuel R. Leno
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US5165441032
  • Market cap
    $6.43bn
  • Employees
    834
  • Shares in issue
    70.87m
  • Exchange
    NASDAQ
  • Index
    S&P 400 Mid Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.